Please assess the completion status of the following clinical trial:

Trial Title: Multiple Dose Effect of Oxytocin on Males With High or Low Trait Anxiety

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: EARLY_PHASE1
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion:~* healthy adult males~Exclusion:~* past or current psychiatric or neurological disorder~* head trauma~* substance abuse~* medication~* fMRI contraindications (e.g. metal implants)

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 30 Years
- Healthy Volunteers: t

Study Arms:
- High anxiety group (single dose) (Type: EXPERIMENTAL): Oxytocin nasal spray or placebo nasal of one dose in subjects with high trait anxiety.
- High anxiety group (3 doses) (Type: EXPERIMENTAL): Oxytocin nasal spray or placebo nasal spray interleaved during the 5 days( on the 1st,3rd and 5th day),24 IU per day in subjects with high trait anxiety.
- High anxiety group (5 doses) (Type: EXPERIMENTAL): Oxytocin nasal spray or placebo nasal spray for 5 days,24 IU per day in subjects with high trait anxiety.
- Low anxiety group (single dose) (Type: EXPERIMENTAL): Oxytocin nasal spray or placebo nasal spray of one dose in subjects with low trait anxiety.
- Low anxiety group (3 doses) (Type: EXPERIMENTAL): Oxytocin nasal spray or placebo nasal spray interleaved during the 5 days( on the 1st,3rd and 5th day),24 IU per day in subjects with low trait anxiety.
- Low anxiety group (5 doses) (Type: EXPERIMENTAL): Oxytocin nasal spray or placebo nasal spray for 5 days in subjects with low trait anxiety.

Based on this trial design, predict the completion outcome and termination type (if applicable).